US Stock MarketDetailed Quotes

Interpace Biosciences Inc (IDXG)

Watchlist
  • 2.135
  • -0.065-2.95%
15min DelayClose Apr 17 12:49 ET
9.34MMarket Cap11.86P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Interpace Biosciences Inc (IDXG) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
25.48%5.83M
80.49%2.14M
-8.41%1.94M
-62.96%520K
2,229.31%1.24M
22.62%4.65M
3.86%1.18M
91.49%2.12M
241.61%1.4M
-105.12%-58K
Net income from continuing operations
266.68%24.58M
1,104.52%22.66M
-45.64%911K
-126.26%-640K
132.63%1.65M
242.99%6.7M
-7.88%1.88M
372.96%1.68M
1,292.57%2.44M
101.71%708K
Depreciation and amortization
9.76%821K
4.74%221K
11.64%211K
5.85%199K
18.75%190K
-53.28%748K
13.44%211K
-46.31%189K
-66.78%188K
-67.81%160K
Deferred tax
---21.25M
----
----
----
----
--0
----
----
----
----
Other non cash items
-70.91%169K
-47.37%40K
-19.82%348K
-345.65%-205K
-111.97%-14K
-30.75%581K
-75.08%76K
45.64%434K
-120.91%-46K
631.25%117K
Change In working capital
135.01%1.29M
140.62%470K
289.71%461K
178.09%959K
42.46%-603K
-197.65%-3.68M
23.98%-1.16M
-126.50%-243K
-73.69%-1.23M
-1,461.04%-1.05M
-Change in receivables
183.53%2.9M
125.88%317K
216.38%1.27M
228.08%1.54M
-586.96%-224K
-1,626.87%-3.47M
-5,000.00%-1.23M
-255.51%-1.09M
-387.80%-1.2M
118.33%46K
-Change in payables and accrued expense
-2,945.65%-1.4M
-52.28%178K
-185.57%-593K
-270.70%-536K
68.44%-450K
96.36%-46K
130.65%373K
464.74%693K
417.17%314K
-689.26%-1.43M
-Change in other current assets
-420.55%-234K
87.20%-21K
----
----
-80.47%67K
182.02%73K
38.11%-164K
-14.44%237K
-64.90%-343K
220.56%343K
-Change in other current liabilities
111.39%27K
97.16%-4K
102.33%2K
2,400.00%25K
136.36%4K
-117.43%-237K
-116.92%-141K
-165.65%-86K
100.65%1K
47.62%-11K
Cash from discontinued investing activities
Operating cash flow
25.51%5.83M
80.57%2.14M
-8.41%1.94M
-62.96%520K
2,229.31%1.24M
22.62%4.65M
3.86%1.18M
91.49%2.12M
241.61%1.4M
-105.12%-58K
Investing cash flow
Cash flow from continuing investing activities
59.36%-356K
70.54%-38K
77.59%-117K
-2.03%-201K
0
-906.90%-876K
9.15%-129K
-250.00%-522K
13.60%-197K
56.92%-28K
Net PPE purchase and sale
59.36%-356K
70.54%-38K
77.59%-117K
-2.03%-201K
--0
-86.38%-876K
9.15%-129K
-243.42%-522K
-77.48%-197K
56.92%-28K
Net business purchase and sale
----
----
----
----
----
--0
--0
--0
----
----
Cash from discontinued investing activities
Investing cash flow
59.36%-356K
70.54%-38K
77.59%-117K
-2.03%-201K
--0
-906.90%-876K
9.15%-129K
-250.00%-522K
13.60%-197K
56.92%-28K
Financing cash flow
Cash flow from continuing financing activities
23.70%-4.43M
40.36%-1.02M
40.00%-900K
49.35%-1.01M
-150.00%-1.5M
-15.40%-5.81M
32.58%-1.71M
0.00%-1.5M
-185.71%-2M
-100.00%-600K
Net issuance payments of debt
21.43%-4.4M
34.20%-987K
39.13%-913K
50.00%-1M
-150.00%-1.5M
-124.00%-5.6M
---1.5M
0.00%-1.5M
-185.71%-2M
-100.00%-600K
Proceeds from stock option exercised by employees
60.87%-18K
----
----
----
----
-43.75%-46K
----
----
----
----
Net other financing activities
91.93%-13K
----
----
----
----
93.56%-161K
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
23.70%-4.43M
40.36%-1.02M
40.00%-900K
49.35%-1.01M
-150.00%-1.5M
-15.40%-5.81M
32.58%-1.71M
0.00%-1.5M
-185.71%-2M
-100.00%-600K
Net cash flow
Beginning cash position
-58.23%1.46M
-32.65%1.42M
-75.14%502K
-57.47%1.2M
-58.23%1.46M
-27.55%3.5M
-58.01%2.11M
-60.25%2.02M
-49.75%2.81M
-27.55%3.5M
Current changes in cash
151.25%1.04M
265.95%1.08M
879.79%921K
12.48%-694K
61.37%-265K
-53.16%-2.04M
57.50%-652K
300.00%94K
-53.38%-793K
-189.32%-686K
End cash Position
71.46%2.51M
71.46%2.51M
-32.65%1.42M
-75.14%502K
-57.47%1.2M
-58.23%1.46M
-58.23%1.46M
-58.01%2.11M
-60.25%2.02M
-49.75%2.81M
Free cash flow
45.23%5.48M
99.05%2.1M
14.24%1.82M
-73.57%319K
1,536.05%1.24M
13.59%3.77M
5.71%1.06M
67.26%1.59M
302.33%1.21M
-108.05%-86K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 25.48%5.83M80.49%2.14M-8.41%1.94M-62.96%520K2,229.31%1.24M22.62%4.65M3.86%1.18M91.49%2.12M241.61%1.4M-105.12%-58K
Net income from continuing operations 266.68%24.58M1,104.52%22.66M-45.64%911K-126.26%-640K132.63%1.65M242.99%6.7M-7.88%1.88M372.96%1.68M1,292.57%2.44M101.71%708K
Depreciation and amortization 9.76%821K4.74%221K11.64%211K5.85%199K18.75%190K-53.28%748K13.44%211K-46.31%189K-66.78%188K-67.81%160K
Deferred tax ---21.25M------------------0----------------
Other non cash items -70.91%169K-47.37%40K-19.82%348K-345.65%-205K-111.97%-14K-30.75%581K-75.08%76K45.64%434K-120.91%-46K631.25%117K
Change In working capital 135.01%1.29M140.62%470K289.71%461K178.09%959K42.46%-603K-197.65%-3.68M23.98%-1.16M-126.50%-243K-73.69%-1.23M-1,461.04%-1.05M
-Change in receivables 183.53%2.9M125.88%317K216.38%1.27M228.08%1.54M-586.96%-224K-1,626.87%-3.47M-5,000.00%-1.23M-255.51%-1.09M-387.80%-1.2M118.33%46K
-Change in payables and accrued expense -2,945.65%-1.4M-52.28%178K-185.57%-593K-270.70%-536K68.44%-450K96.36%-46K130.65%373K464.74%693K417.17%314K-689.26%-1.43M
-Change in other current assets -420.55%-234K87.20%-21K---------80.47%67K182.02%73K38.11%-164K-14.44%237K-64.90%-343K220.56%343K
-Change in other current liabilities 111.39%27K97.16%-4K102.33%2K2,400.00%25K136.36%4K-117.43%-237K-116.92%-141K-165.65%-86K100.65%1K47.62%-11K
Cash from discontinued investing activities
Operating cash flow 25.51%5.83M80.57%2.14M-8.41%1.94M-62.96%520K2,229.31%1.24M22.62%4.65M3.86%1.18M91.49%2.12M241.61%1.4M-105.12%-58K
Investing cash flow
Cash flow from continuing investing activities 59.36%-356K70.54%-38K77.59%-117K-2.03%-201K0-906.90%-876K9.15%-129K-250.00%-522K13.60%-197K56.92%-28K
Net PPE purchase and sale 59.36%-356K70.54%-38K77.59%-117K-2.03%-201K--0-86.38%-876K9.15%-129K-243.42%-522K-77.48%-197K56.92%-28K
Net business purchase and sale ----------------------0--0--0--------
Cash from discontinued investing activities
Investing cash flow 59.36%-356K70.54%-38K77.59%-117K-2.03%-201K--0-906.90%-876K9.15%-129K-250.00%-522K13.60%-197K56.92%-28K
Financing cash flow
Cash flow from continuing financing activities 23.70%-4.43M40.36%-1.02M40.00%-900K49.35%-1.01M-150.00%-1.5M-15.40%-5.81M32.58%-1.71M0.00%-1.5M-185.71%-2M-100.00%-600K
Net issuance payments of debt 21.43%-4.4M34.20%-987K39.13%-913K50.00%-1M-150.00%-1.5M-124.00%-5.6M---1.5M0.00%-1.5M-185.71%-2M-100.00%-600K
Proceeds from stock option exercised by employees 60.87%-18K-----------------43.75%-46K----------------
Net other financing activities 91.93%-13K----------------93.56%-161K----------------
Cash from discontinued financing activities
Financing cash flow 23.70%-4.43M40.36%-1.02M40.00%-900K49.35%-1.01M-150.00%-1.5M-15.40%-5.81M32.58%-1.71M0.00%-1.5M-185.71%-2M-100.00%-600K
Net cash flow
Beginning cash position -58.23%1.46M-32.65%1.42M-75.14%502K-57.47%1.2M-58.23%1.46M-27.55%3.5M-58.01%2.11M-60.25%2.02M-49.75%2.81M-27.55%3.5M
Current changes in cash 151.25%1.04M265.95%1.08M879.79%921K12.48%-694K61.37%-265K-53.16%-2.04M57.50%-652K300.00%94K-53.38%-793K-189.32%-686K
End cash Position 71.46%2.51M71.46%2.51M-32.65%1.42M-75.14%502K-57.47%1.2M-58.23%1.46M-58.23%1.46M-58.01%2.11M-60.25%2.02M-49.75%2.81M
Free cash flow 45.23%5.48M99.05%2.1M14.24%1.82M-73.57%319K1,536.05%1.24M13.59%3.77M5.71%1.06M67.26%1.59M302.33%1.21M-108.05%-86K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +14.09%
Sample Name
Sample Code
 +3.93%
Sample Name
Sample Code
 +2.06%
4
United States Oil Fund LP
USO
-1.12%
5
United States Gasoline Fund Lp
UGA
-2.10%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +22.28%
Sample Name
Sample Code
 +20.52%
Sample Name
Sample Code
 +19.71%
4
Zai Lab
ZLAB
+16.97%
5
Legend Biotech
LEGN
+16.57%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -